Transparency creates fruitful pharma-patient group partnershipsCollaboration between pharma and patient organisations can yield fantastic results – but conflict of interest concerns can stop Share XTransparency creates fruitful pharma-patient group partnershipshttps://pharmaphorum.com/views-analysis-patients/transparency-creates-fruitful-pharma-patient-group-partnerships/
Fair market value for patientsFair Market Value (FMV) payment is not a new concept to the life science industry. It has for Share XFair market value for patientshttps://pharmaphorum.com/views-analysis-patients/fair-market-value-for-patients/
From poison to lifeline – how my views on chemotherapy changed as a cancer patientCancer survivor Brooke Gant tells us about her experiences with chemotherapy. In 2017, I started off being a Share XFrom poison to lifeline – how my views on chemotherapy changed as a cancer patienthttps://pharmaphorum.com/views-analysis-patients/from-poison-to-lifeline-how-my-views-on-chemotherapy-changed-as-a-cancer-patient/
R&D Roundup: Pharma gets in on the biotech boomSome good news for the UK industry in turbulent times is always welcome, and several announcement this month Share XR&D Roundup: Pharma gets in on the biotech boomhttps://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-pharma-gets-in-on-the-biotech-boom/
The patient perspective on advocacyGrowing up with the shadow of Huntington’s disease (HD) means Seth Rotberg understands the importance of peer support Share XThe patient perspective on advocacyhttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/inspire-patient-advocacy-seth-rotberg/
Boosting clinical trial recruitment through patient engagementOver the years, many hands have been wrung over clinical trial recruitment – low participation rates are common Share XBoosting clinical trial recruitment through patient engagementhttps://pharmaphorum.com/views-analysis-patients/boosting-clinical-trial-recruitment-through-patient-engagement/
Harnessing RWE in rare diseasesAhead of eyeforpharma Philadelphia 2019, Sonal Bhatia, Pfizer’s vice president, North America medical lead, rare disease talked to Share XHarnessing RWE in rare diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/harnessing-rwe-in-rare-diseases/
The unmet needs of bleeding disorder patientsAhead of eyeforpharma Philadelphia 2019, we talk to speaker and haemophilia advocate Michelle Rice about the changing landscape Share XThe unmet needs of bleeding disorder patientshttps://pharmaphorum.com/views-analysis-patients/the-unmet-needs-of-bleeding-disorder-patients/
Abilify MyCite and innovating in digital healthpharmaphorum’s Paul Tunnah spoke with Otsuka Pharmaceutical’s North America Pharmaceutical Business president and CEO Kabir Nath about the Share XAbilify MyCite and innovating in digital healthhttps://pharmaphorum.com/views-analysis-digital/abilify-mycite-and-innovating-in-digital-health/
